Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.75B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 3 |
Procter & Gamble
PG
|
+$980M |
| 4 |
Apple
AAPL
|
+$894M |
| 5 |
Amazon
AMZN
|
+$815M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$806M |
| 2 |
Palo Alto Networks
PANW
|
+$726M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$654M |
| 4 |
Toronto Dominion Bank
TD
|
+$494M |
| 5 |
Enbridge
ENB
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.1% |
| 2 | Technology | 15.76% |
| 3 | Industrials | 7.8% |
| 4 | Healthcare | 7.3% |
| 5 | Consumer Discretionary | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
iShares JPMorgan EM High Yield Bond ETF
EMHY
$638M
| $1.62M | ﹤0.01% |
44,458
-465
| -1% | -$16.1K |
|
3177
Titan Machinery
TITN
$429M
| $1.62M | ﹤0.01% |
55,955
+39,095
| +232% | +$1.01M |
|
3178
BridgeBio Pharma
BBIO
$15.6B
| $1.61M | ﹤0.01% |
40,007
+20,748
| +108% | +$623K |
|
|
JPI
3179
DELISTED
Nuveen Preferred Securities & Income Opportunities Fund
JPI
| $1.61M | ﹤0.01% |
88,119
-10,310
| -10% | -$178K |
|
3180
Macerich
MAC
$7.01B
| $1.61M | ﹤0.01% |
104,264
+39,111
| +60% | +$466K |
|
3181
UMB Financial
UMBF
$11.5B
| $1.61M | ﹤0.01% |
19,233
+5,416
| +39% | +$381K |
|
|
AEL
3182
DELISTED
American Equity Investment Life Holding Company
AEL
| $1.6M | ﹤0.01% |
28,740
-80,862
| -74% | -$4.39M |
|
|
ESGR
3183
DELISTED
Enstar Group
ESGR
| $1.6M | ﹤0.01% |
5,441
+1,263
| +30% | +$330K |
|
3184
Primoris Services
PRIM
$4.48B
| $1.6M | ﹤0.01% |
48,108
+4,171
| +9% | +$130K |
|
|
PMT
3185
PennyMac Mortgage Investment
PMT
$824M
| $1.6M | ﹤0.01% |
106,862
+12,787
| +14% | +$171K |
|
3186
Capital Group Core Bond ETF
CGCB
$5.77B
| $1.59M | ﹤0.01% |
+60,225
| New | +$1.53M |
|
3187
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$399M
| $1.59M | ﹤0.01% |
18,843
-13,279
| -41% | -$1.15M |
|
3188
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.28B
| $1.59M | ﹤0.01% |
74,885
+11,614
| +18% | +$235K |
|
3189
Ultragenyx Pharmaceutical
RARE
$2.61B
| $1.59M | ﹤0.01% |
33,247
-2,502
| -7% | -$97K |
|
|
KLG
3190
DELISTED
WK Kellogg Co
KLG
| $1.59M | ﹤0.01% |
+120,723
| New | +$1.36M |
|
3191
Assured Guaranty
AGO
$3.38B
| $1.59M | ﹤0.01% |
21,198
+3,757
| +22% | +$248K |
|
3192
TriNet
TNET
$3.16B
| $1.59M | ﹤0.01% |
13,342
+4,840
| +57% | +$553K |
|
|
RC
3193
Ready Capital
RC
$306M
| $1.58M | ﹤0.01% |
154,667
+29,481
| +24% | +$300K |
|
3194
Hanover Insurance
THG
$7.84B
| $1.58M | ﹤0.01% |
13,037
+289
| +2% | +$34.4K |
|
3195
Renaissance IPO ETF
IPO
$165M
| $1.58M | ﹤0.01% |
41,990
-26,260
| -38% | -$870K |
|
3196
FlexShares Quality Dividend Defensive Index Fund
QDEF
$562M
| $1.58M | ﹤0.01% |
26,780
-39,358
| -60% | -$2.21M |
|
3197
GATX Corp
GATX
$6.38B
| $1.58M | ﹤0.01% |
13,145
+6,125
| +87% | +$676K |
|
3198
Capital Southwest
CSWC
$1.59B
| $1.58M | ﹤0.01% |
66,468
-20,263
| -23% | -$452K |
|
3199
Bar Harbor Bankshares
BHB
$681M
| $1.57M | ﹤0.01% |
53,653
+4,419
| +9% | +$116K |
|
3200
Collegium Pharmaceutical
COLL
$875M
| $1.57M | ﹤0.01% |
50,972
+7,722
| +18% | +$193K |
|
Similar funds
Royal Bank of Canada's Q4 2023 Portfolio in Review
As of Q4 2023, Royal Bank of Canada held 7,942 positions worth $428B, up 16% from $369B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada deployed $17.2B of net new capital in Q4 2023, opening 467 new positions and adding to 4,112 existing holdings. Its largest new stake was Franklin Income Focus ETF: 394,628 shares worth $10.1M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was PepsiCo, an estimated $806M trimmed.
- Royal Bank of Canada's largest Q4 2023 buy was Franklin Income Focus ETF: 394,628 shares worth $10.1M.
- Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $8.75B increase.
- Royal Bank of Canada's biggest Q4 2023 reduction was PepsiCo, cutting an estimated $806M.
- Royal Bank of Canada fully exited Activision Blizzard in Q4 2023, selling an estimated $69.3M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $428B portfolio in Q4 2023.
- Royal Bank of Canada opened 467 new positions and closed 401 in Q4 2023.
- Royal Bank of Canada's portfolio value rose 16% quarter-over-quarter to $428B.
Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.